Pharmazeutische Zusammensetzung und Tablette
Anmelder: Mitsubishi Chemical Corporation 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4799613
- Anmeldetag
- 24. Oktober 2024
- Veröffentlichung
- 1. Mai 2025
- Rechtsraum
- EP
Abstract
Disclosed is a pharmaceutical composition providing a tablet capable of retaining a tablet shape over prolonged duration after being ingested, while the content of polyvinyl alcohol is suppressed. The pharmaceutical composition comprises a polyvinyl alcohol-based resin (A), a polyhydric phenol compound (B), and amorphous silica (C). The content of the amorphous silica (C) ranges from 0.1 to 20 parts by mass based on 100 parts by mass of the polyvinyl alcohol-based resin. Also, disclosed is a tablet comprising the pharmaceutical composition as a matrix composition (I). and an active pharmaceutical ingredient (II) which is dispersed in the matrix composition (I), wherein the content of the active pharmaceutical ingredient (II) ranges from 30 to 90% by mass.
Anmelder
- Firma
- Mitsubishi Chemical Corporation
- Land
- 🇯🇵 Japan
Japanisches Chemieunternehmen mit Sitz in Tokio, Teil der Mitsubishi-Chemical-Gruppe. Das Unternehmen entwickelt Grund- und Spezialchemikalien, Kunststoffe, Materialien für Elektronik und Energiespeicher sowie Pharma- und Life-Science-Produkte.
3.888 Patente in unserer Datenbank